Nikhil S Sakle

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Tyrosine Kinase

Signaling Pathway

Top Venues

Naunyn-Schmiedeberg's archives of pharmacology

Nutrition and cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Prasanna Mohite, Deepak K Lokwani, Nikhil S Sakle
Exploring the therapeutic potential of SGLT2 inhibitors in cancer treatment: integrating in silico and in vitro investigations. Naunyn-Schmiedeberg's archives of pharmacology (2024)
Prasanna Mohite, Deepak K Lokwani, Nikhil S Sakle
Exploring the therapeutic potential of SGLT2 inhibitors in cancer treatment: integrating in silico and in vitro investigations. Naunyn-Schmiedeberg's archives of pharmacology 397 (8) (2024)
Prasanna Mohite, Deepak K Lokwani, Nikhil S Sakle
Exploring the therapeutic potential of SGLT2 inhibitors in cancer treatment: integrating in silico and in vitro investigations. Naunyn-Schmiedeberg's archives of pharmacology 397 (8) (2024)
Prasanna Mohite, Deepak K Lokwani, Nikhil S Sakle
Exploring the therapeutic potential of SGLT2 inhibitors in cancer treatment: integrating in silico and in vitro investigations. Naunyn-Schmiedeberg's archives of pharmacology 397 (8) (2024)
Prasanna Mohite, Deepak K Lokwani, Nikhil S Sakle
Exploring the therapeutic potential of SGLT2 inhibitors in cancer treatment: integrating in silico and in vitro investigations. Naunyn-Schmiedeberg's archives of pharmacology 397 (8) (2024)
Komal S Wakle, Santosh N Mokale, Nikhil S Sakle
Emerging perspectives: unraveling the anticancer potential of vitamin D 3 . Naunyn-Schmiedeberg's archives of pharmacology (2023)
Nikhil S Sakle, Shweta A More, Santosh N Mokale
Alysicarpus vaginalis Bio-Actives as ESR Signaling Pathway Inhibitor for Breast Cancer Treatment: A Network Pharmacology Approach. Nutrition and cancer (2021)